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ABSTRACT
Functional analysis of mammalian genes in vivo is
primarily achieved through analysing knockout
mice. Now that the sequencing of several mamma-
lian genomes has been completed, understanding
functions of all the genes represents the next major
challenge in the post-genome era. Generation of
knockout mutant mice has currently been achieved
by many research groups but only by making
individual knockouts, one by one. New technolo-
gical advances and the refinements of existing
technologies are critical for genome-wide targeted
mutagenesis in the mouse. We describe here new
recombineering reagents and protocols that enable
recombineering to be carried out in a 96-well
format. Consequently, we are able to construct
96 conditional knockout targeting vectors simulta-
neously. Our new recombineering system makes it
a reality to generate large numbers of precisely
engineered DNA constructs for functional genomics
studies.
INTRODUCTION
Sequencing and analysis of the mouse and human
genomes have led to the identiﬁcation of  25000
genes as well as hundreds of conserved non-coding
regions (1–3). Functional characterization of the genes
and the potential regulatory elements genome-wide
represents a major challenge in the post-genome sequen-
cing era. While there are a range of experimental and
informatics tools that address gene function, analysing
knockout (KO) mice produced through gene targeting
in mouse embryonic stem (ES) cells is still the most
widely used approach to understand mammalian gene
function (4). KO mutant lines have been generated for
hundreds of mouse genes (5). Analyses of these mutant
mice have provided fundamental insights into mammalian
gene functions. In general, there are several phenotypic
outcomes in the KO mice. The mutant mice may have the
exact phenotypes anticipated based on a gene’s expression
pattern, in vitro assays, bioinformatics predictions or
symptoms in human patients. Yet, in some cases,
the mutant mice may not have any obvious phenotype,
which might be due to genetic redundancy, nature of the
KO alleles, genetic background eﬀects, investigator’s
knowledge or incomplete phenotyping spectrums. For
other genes, the mutants die in uteri owing to the critical
roles of these genes in embryonic development, thereby
precluding studying their functions in late development
or in speciﬁc tissues of adult mice.
To circumvent the embryonic lethality problem and
to investigate gene function temporally and spatially,
conditional knockout (cko) approaches have been
developed (6,7). The current cko strategy takes advantage
of the Cre-loxP site-speciﬁc recombination system that
functions well in mouse cells (8). In a typical cko allele, the
critical exon(s) of a gene is ﬂanked by two loxP sites
so that it can be deleted by spatial and temporal
Cre expression. With the advances of DNA manipulation
technologies, it is now possible to generate a multi-
purpose allele of a gene that can serve as a conventional
KO, a conditional KO and a reporter allele (9).
The ﬁrst step in generating a cko allele is to construct a
targeting vector in E. coli that is subsequently transfected
into mouse ES cells for homologous recombination.
We and others have previously described methods for
constructing targeting vectors using recombineering,
which is based on highly eﬃcient homologous recombina-
tion systems from bacteriophages (10–15). In the system
using homologous recombination encoded by l phage
that we developed, a temperature-dependent repressor
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the recombination functions of l phage can be transiently
supplied by shifting cultures to 428C for 15min (14,16).
Three proteins encoded by l are required for the
homologous recombination function in recombineering
(17–19): Exo, Beta and Gam. Exo is a 50–30 exonuclease
that acts on linear double-strand DNA (dsDNA) to
generate 30 single-strand DNA (ssDNA) overhangs for
recombination. Beta binds to the ssDNA overhangs that
are longer than 35nt and stimulates complementary
strand annealing. The recombination is further enhanced
by Gam, which inhibits RecBCD-dependent, linear DNA
degradation activities of the host cell. The l prophage-
based recombineering systems have proven to be very
eﬃcient due to the fact that the three genes are expressed
in single copy from their natural operon and from the
strong promoter, pL, and that the three proteins are in
appropriate molar ratio as they form a complex in vivo.
The tightly regulated expression also ensures that the Beta
and Exo proteins are present only after induction. This,
together with the short induction time (15min) for the
expression of the recombination activities, help to mini-
mize the potential genomic rearrangements caused by
prolonged presence of the phage Red recombination
proteins. To make a cko vector from a BAC, the ﬁrst
step is usually to transform the BAC DNA into
recombineering-competent E. coli cells. Subsequently,
selection cassettes with loxP sites are inserted via
recombineering into genomic regions that ﬂank the exon
to be deleted (10).
We describe here a high-throughput recombineering
system, which can generate conditional targeting vectors
in a rapid eﬃcient manner. A key reagent for this new
system includes a complete l phage that is replication
defective in BAC-harbouring DH10B E. coli cells but still
retains its full heat-inducible homologous recombination
functions. A second reagent useful for high-throughput
recombineering is a set of low-copy plasmids (pSim) that
contain exo, bet and gam in their native phage operon, pL,
under l CI repressor control (20). By using cells carrying
either of these two new reagents, thousands of BAC clones
can be easily made recombineering competent by either
simple l infection or plasmid transformation. Further
improvement of recombineering in these systems allowed
all the steps for making targeting vectors to be performed
in 96-well plates, making the whole process suitable for
high-throughput operations. Our new recombineering
system described here has solved a key technical
bottleneck for the genome-wide targeted mutagenesis
programmes in the mouse (5,21).
MATERIALS AND METHODS
Constructionof the replication-defective phage
The replication-defective l phage, l cI857 ind1
CroTYR26amber PGLN59amber rex54 tetRA, was created by
combining several diﬀerent mutations to mimic the
defective prophage strain that we have used for most of
our recombineering studies. The cI857 mutation allows
temperature induction by inactivating the CI repressor.
The Cro mutation enhances pL operon and recombination
gene expression analogous to the Cro deletion of the
defective prophages. Wild-type l lysogens die within 7min
after a normal prophage induction due to in situ l DNA
replication in the bacterial chromosome carried out by
O and P functions of l (22). The P mutation causes a
defect in l replication allowing induction of the prophage
for at least 15min. Replication-competent lysogens kill the
host with less than a 10-min induction. The tetRA genes
are added to select for the presence of the lysogenic
prophage in the strain using tetracycline resistance.
The construction of l cI857 CroTYR26amber was described
previously (23). The amber mutation in Cro is at codon 26
changing it from a tyrosine TAT codon to the amber TAG
codon. A high-titre lysate was prepared from this mutant
phage on strain N720, which contains the supF amber
suppressor for tyrosine tRNA allowing Cro expression by
the phage. Note that this phage mutant does not form
plaques on a non-suppressor strain like W3110 or DH10B
or even on a supE glutamine suppressor tRNA strain;
presumably because glutamine cannot be substituted for
tyrosine at this position in Cro.
The mutation PGLN59amber was ﬁrst created by Campbell
(24) as an amber (sus) mutation in the l replication gene
P at glutamine codon 59. This phage mutant called l P80
forms plaques on the C600 supE suppressor strain but not
on DH10B or the N720 supF strain, i.e. just the reverse of
the Cro mutation above. This mutation is a C4T change
in position 39759 of the l DNA sequence. A high-titre
lysate was prepared from this mutant phage on strain
C600. From the pure phage preparation, we ampliﬁed the
entire P gene carrying the amber mutation by PCR using
Invitrogen Platinum HiF polymerase and cleaned the
product with a Qiagen kit. We next did recombineering
with the phage l cI857 CroTYR26amber by crossing it with
the linear DNA PCR product carrying the P80 mutation
using the protocol outlined in the Oppenheim’s article
above (23).
We detected the recombinant phage containing both the
Cro and P amber mutations on a tryptone agar Petri plate
overlaid with two bacterial top agar layers of 2.5ml each.
In the ﬁrst agar layer was the N720 bacterial strain on
which the Cro amber mutant parent phage could form
plaques but on which the double Cro P amber mutant
would not form plaques because of the P80 mutation.
In the top layer was the LE392 strain, which allows both
amber mutations to be functionally suppressed and which
is used for infection by phage from the recombineering
cross described above. The desired double mutant,
recombinant l cI857 ind1 CroTYR26amberPGLN59amber is
distinguished from the parental l cI857 CroTYR26amber
because the P mutant forms cloudy plaques due to its
inability to grow on the bottom layer, and the P
þ parental
phage forms clear plaques by growing on both layers.
These cloudy recombinant plagues were puriﬁed on LE392
and tested for plaquing on LE392, N720 and C600.
As expected, they formed plaques eﬃciently only on the
LE392 double suppressor strain. We ampliﬁed the DNA
of the P gene from the recombinant and demonstrated
that it contained the mutation P80 creating a BfaI site.
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genes with tetRA encoding tetracycline resistance. This
was done following the same procedure as outlined
previously (23) using recombineering with the l cI857
ind1 CroTYR26amberPGLN59amber recombinant phage and a
PCR product of the tetRA genes with ﬂanking homologies
designed to delete the rexArexB genes. The recombineer-
ing was done in the LE392 derivatives. Following the
recombineering cross, the resultant phage lysate was used
to infect LE392, and tetracycline-resistant lysogens were
selected on LB-tet plates at 328C. Lysogens were puriﬁed
and tested for sensitivity to phages l, limm21, T4, and
T4 rII. The strain was resistant (immune) to l but not
limm21 or T4 as expected for a l lysogen. This l lysogen
was sensitive to T4 rII which is expected if the T4 rII
exclusion functions RexAB are absent. The lysogen was
induced to produce a phage lysate by shifting an
exponentially growing culture in LB to 428C for 15min,
and then shifting to 398C until cell lysis (60–90min). For
long term storage, the l lysate was prepared by
centrifuging the lysed culture with a couple drops of
added chloroform. We routinely obtained l lysates with
titres greater than 10
9p.f.u./ml.
Construction of pSim plasmids
Plasmid pSim6 was constructed by recombination
the l defective prophage into pSC101 plasmid backbone
(20). The Amp
R coding sequence was present as
a substitute for the rexAB genes. We made pSim17
and pSim18 by replacing amp in pSim6 with either
Blasticidin-or Hygromycin-resistant coding sequences
using the recombineering functions expressed from the
plasmid.
PCR products forrecombineering
All DNA oligos in this study were purchased from Sigma.
Linear templates to be used for PCR ampliﬁcation were
prepared as follows: The retrieval vector (PL611) was
digested with EcoRI and BamHI, the loxP-F3-PGK-EM7-
Neo-F3 selection cassette was cut with NotI and SalI, and
the I-SceI-Bsd-I-CeuI cassette was digested with EcoRI
and BamHI. The digestion mixtures were run on a gel
and bands corresponding to Bsd (526bp), Neo (2kb) and
PL611 (3kb) were excised and puriﬁed using
Qiagen puriﬁcation kit. To avoid the background
from uncut plasmids carrying these cassettes, we tested
the gel-puriﬁed PL611 and the two selection cassettes by
transforming 1.0ng of them into DH10B cells. If there
were any background drug-resistant colonies, the cassettes
were re-puriﬁed and tested again until they were clean,
thereby ensuring that all the Bsd
R or Kan
R cells selected
out in liquid media after recombineering should be the
recombinant ones. The restriction maps of the selection
cassettes and PL611 are depicted in Supplementary
Figures 2–6.
To generate products for targeting or retrieving, 1.0 ng
of each of the three linear puriﬁed products above was
used as a template for PCR reaction. PCR ampliﬁcation
was carried out using Extensor Hi-Fidelity PCR Master
Mix 2 (2X, ABgene). Twenty-ﬁve microlitres of the master
mix was added to 1ml of template (1.0ng), 2ml of each
primer (10mM) and 20ml of PCR-grade water. PCR was
performed using PTC-225 PCR machine (Peltier Thermal
Cycler) with the following settings: 948C for 4min, this
was followed by 35 cycles of 948C for 30s, 608C for 30s
and 688C for 1min (Bsd) or 2–3min (Neo and retrieval
backbone). This was then followed by 688C for 5min.
After PCR reactions, 0.5ml of exonuclease I (10U, from
either New England Biolabs or Epicentre) was added
per 50ml of PCR products and incubated at 378C
for 1h followed by heat inactivation at 808C for 20min.
The PCR products were then puriﬁed using Qiagen
mini-preparation columns and eluted in 50mlo f
PCR-grade water.
For 96-well operations, all primers were synthesised
in 96-well plates so that they could be used directly in a
96-well PCR reaction plate. After Exo I treatment and
heat inactivation, PCR products were precipitated with
ethanol in 96-well PCR plates. Here, 100ml ethanol with
2ml 5N NaCl were added to each well of 50ml PCR
reaction. DNA was precipitated by centrifuging the plate
at 3700r.p.m. (2250g) for 30min and washed once with
70% ethanol. Air-dried PCR products were dissolved in
100mM CaCl2 for chemical transformation. Alternatively,
for electroporation, DNA was dissolved in 50ml water.
Three micrograms of ampliﬁed DNA was usually
obtained from one PCR reaction.
Making one orafew targeting vectors using themobile
recombineering reagents
Targeting selection cassettes to BACs.
(1) Using replication-defective l phage
Day 1. Inoculate BAC cells into 1ml LB with
Chloramphenical (12.5mg/ml), 1% maltose, for overnight
growth at 378C with shaking.
Day 2. Cells were collected and washed once with 1ml
10mM MgSO4 and resuspended in 100ml 10mM MgSO4.
One microlitre containing greater than 1 million lambda
phage was added to 100ml of the BAC cells and the
mixture was incubated at 328C for 20min. One millilitre
LB was added to the tube that was incubated for another
hour before the cells are plated to a Tet-LB plate. The
plate was incubated at 328C for overnight. The lysoge-
nization frequency was  1%, as expected, and infection
yielded  10000 Tet
R colonies.
(2) Using pSim plasmids
Day 1. Inoculate BAC cells into 1ml LB with
chloramphenical (12.5mg/ml), for overnight growth at
378C with shaking.
Day 2. Cells were collected and washed with cold water
three times and were electroporated with pSim18 (1.0ng)
in 50ml water. Electroporation condition: 200 Ohms
(capacitance, 25 microFD, 0.1cm gap, 1.8kV). The
transformation mixture was added with 1ml LB and
was incubated for 1h at 328C. The cells were plated onto
a LB-Hygro (75mg/ml) plate and incubated at 328C for
overnight.
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collected and were washed with 100mM MgCl2, 100mM
CaCl2 and then with 100mM CaCl2. Finally, cells were
resuspended in 50ml 100mM CaCl2 with 1.0ng pSim18.
The cell–DNA mixture was heat shocked at 428C for
2min. The transformation mixture was added with
1ml LB and was incubated for 1h at 328C before plated
onto a LB-Hygro plate. The plate was incubated at
328C for overnight.
Day 3. Pick up one Tet
R or Hygro
R colony
and inoculate into 1ml LB with chloramphenical and
tetracycline (12.5mg/ml each) or hygromycin (75mg/ml),
for overnight growth at 328C with shaking.
Day 4. Inoculate 25, 35, 45 and 55ml of the overnight
culture into four 15-ml tubes (or into four wells of a
96-well deep plate) with 1ml fresh LB in each tube. Shake
at 328C for 2h. Without measuring OD, transfer the
cells from the four tubes into wells of a 428C heat block
(Grant Instrument, Cambridge, UK). Incubate for 15min
without shaking. Transfer the heat block to an ice bucket.
The temperature of heat block dropped to 08C within
2min. The metal heat block was chilled on ice for 5min.
Cells were transferred to four 1.5-ml eppendorf tubes and
centrifuged at maximum speed for 25s and combined at
the washing steps. For using electroporation, cells were
washed three times with cold water, electroporated with
Bsd PCR product (3mg) in 50ml water. For using chemical
transformation, cells were collected and were washed once
with 100mM MgCl2, 100mM CaCl2 and then with
100mM CaCl2. Finally, cells were resuspended in 50ml
100mM CaCl2 with 3mg Bsd PCR product. Here, 1ml LB
was added to the transformation mixture, which was
incubated for 1h at 328C before plated onto a LB-Bsd
(75mg/ml) plate. Alternatively, the transformation
mixture was added to one well of a 96-well plate that
had 1ml Bsd-LB media (75mg/ml).
Day 5. Pick up 10 Bsd colonies to test whether they still
retained the replication-defective l phage or pSim18 by
growing them either in LB-Tet or LB-Hygro. The positive
cells were used for the next round of recombineering-
targeting Neo cassette to the BACs. If Bsd
R cells were
growing in a 96-well plate, 150ml of the cells were
transferred to another well in the same 96-well plate
that had 1ml of Bsd-Tet-LB or Bsd-Hygro-LB media to
select for retaining the prophage or pSim plasmid.
Recombineering Neo cassette was performed exactly
as described above except recombinants are selected on
LB-Kan plates (20mg/ml).
Retrieving. Day 1. Bsd
R-Kan
R-Tet




R (if using pSim18) BAC cells were
inoculated into 1ml LB with the antibiotics for overnight
growth at 328C.
Day 2. Recombineering was performed as
described above using either electroporation or
chemical transformation with PCR-ampliﬁed PL611
( 3mg). Transformants were plated on an Amp
plate (50mg/ml) and grew at 328C for overnight.
Alternatively, transformant mixture was inoculated
into 1ml LB with 50mg/ml ampicillin and grew overnight
at 328C.
Day 3. Individual Amp
R colonies were inoculated into
LB-Amp media. Alternatively, if transformation mixture
was inoculated into LB, plasmid was prepared from the
Amp
R liquid culture and 1.0ng plasmid was transformed
into DH10B or recombineering-competent E. coli cells
(EL350 and DY380). The transformants were selected in
1ml Kan-LB media.
Day 4. Plasmid mini-preparation.
Recombineering formaking 96 targeting vectors
The procedure for manipulating 96 BACs is essentially the
same as described above for making the Meox1 targeting
vector. All BACs in this study except Bcl11a BAC (C3)
were from the end-sequenced and indexed mouse 129 BAC
library (25) and were ordered from the Sanger Institute
Archive group (http://www.sanger.ac.uk/cgi-bin/software/
archives/new_clone_login.cgi). The ﬂow chart in Figure 4
illustrated the recombineering steps for vector construc-
tion in 96-well plates. We used a 12-channel pipette
(Matrix) that has 850ml capacity in the experiments.
Therefore, all recombineering steps in 96-well plates used
850ml LB for the 2h growth of diluted overnight cultures.
Day 1. Individual BACs were inoculated into 850ml
LB medium with 12.5mg/ml Chloramphenical, 1% mal-
tose in a 96-well deep well plate and grew at 378C
overnight.
Day 2. Cells were collected by centrifugation at
3700r.p.m. (2250g)a t4 8C for 5min and were resuspended
in 50ml 10mM MgSO4 solution. Here, 1–10ml phage
lysate was added to the cell suspension. The mixture was
incubated at 328C for 20min. This was followed by the
addition of 500ml LB and 1h incubation at 328C.
Lysogens were selected in Tet-LB media (by adding
500ml Tet-LB at 25mg/ml) at 328C.
Day 3. 25, 35, 45 and 55ml of the Tet
R overnight
culture (OD600 1.2–1.4) was transferred to 850ml
fresh LB in 96-well plates so that cultures from one
original 96-deep-well plate were eventually transferred to
four 96-well plates (Figure 5).
After 2-h growth at 328C, cells were transferred to four
96-well metal heat-blocks at 428C. Cells were kept at 428C
for 15min for induction of recombination functions and
then the heat block was immediately put into wet ice so
that the temperature of the block was lowered to 08C
within 2min. The cooled induced cell cultures were
transferred back to regular 96-well plates that were
centrifuged at 3700r.p.m. for 5min at 08C.
In the chemical transformation protocol, the cells
from four individual 96-well plates were combined and
suspended in 850ml 100mM MgCl2, 100mM CaCl2,
pelleted again and washed with 100mM CaCl2. These
cells were ﬁnally suspended in 50ml ice-cold 100mM
CaCl2 containing the PCR product. The DNA–cell
mixture was heat shocked at 428C for 2min in a
PCR machine and transferred to a 96-well plate
with 500ml fresh LB. The plate was incubated at 328C
for at least 2h before 500ml Bsd (150mg/ml)-LB media
was added to each well.
Day 4. 150ml overnight culture was transferred into
fresh Bsd (75–100mg/ml)-Tet (12.5mg/ml)-LB media and
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saturation.
Day 5. cultures were ready for targeting the Neo cassette
to the BACs. The protocol of targeting the Neo cassette to
BACs in a 96-well plate was performed using the same
procedure for targeting the Bsd cassette as described




R BAC cells were obtained, the
speciﬁc genomic DNA fragments were retrieved to PL611.




cells at 328C were inoculated into fresh LB for 96-well
recombineering using PCR-ampliﬁed PL611.
Recombinant cells carrying the retrieved plasmids were
selected in Ampicillin LB media. Because retrieving a
genomic fragment from a BAC was generally less eﬃcient
than targeting a small selection cassette to a BAC, we
obtained fewer colonies after retrieving. As a result, it may
take up to 2 days to grow enough Amp
R cells for plasmid
preparation from 850ml culture in each well.
Day 3. 96-Well plasmid preparation. We prepared
plasmids using a simple isopropanol/ethanol precipitation
protocol for the crude DNA preparations that were
suﬃcient for re-transformation to remove the background
plasmids. Brieﬂy, Amp
R cells in each well of a 96-well
plate were pelleted and suspended in 250ml P1 solution
(from Qiagen). This was followed by the addition of 250ml
P2 solution to each well. Finally, 350ml N3 solution was
added to each well and mixed. The plate was centrifuged
at 3700r.p.m. for 20min at 48C. The supernatant from
each well was transferred to a new 96-well plate with
750ml isopropanol in each well. DNA was pelleted by
centrifuging the plate at 3700r.p.m. for 30min at 48C.
Plasmid DNA was washed with 70% ethanol, air dried
and ﬁnally dissolved in 50ml water. One microlitre of the
plasmid DNA was transformed into either customarily or
commercially made preparations of chemical competent
DH10B cells. Transformants were selected in 850ml
Kan-LB media (20mg/ml).
Day 4–5. Plasmid DNA was isolated using a commer-
cial 96-well plasmid kit. To conﬁrm the identities of the
retrieved plasmids, they were usually either sequenced at
the plasmid backbone-genome insert junctions or digested
for restriction patterns.
Replacement of theBsd cassette with thelacZ reporter
The lacZ reporter cassette was isolated from PL613
respectively with I-SceI and I-CeuI double digestion
(purchased from New England Biolabs). The puriﬁed
fragment was used for ligating to the retrieved plasmid
digested with I-SceI and I-CeuI.
In a typical ligation, 10ml of puriﬁed digested retrieved
plasmids, 12ml of digested PL613, 2.5ml of T4 DNA ligase
buﬀer and 1ml of T4 DNA ligase (NEB). This reaction
was incubated at room temperature for 2h. Here, 5mlo f
the ligation products was transformed into commercially
purchased chemical competent cells, or to DH10B-l
competent cells for the next recombineering step to
introduce the MC1TK cassette to the plasmid backbone.
The transformed cells were selected on Puro/Kanamycin
plates or in Hygromycin/Kanamycin LB medium,
depending on which reporter was chosen. Puromycin
media (powder) was purchased from InvivoGen.
Recombineering of theMC1TK cassette
To add MC1TK to the targeting vectors for negative
selection in ES cells, we constructed a cassette where
MC1TK-Cm cassette that is ﬂanked by  600bp sequences
identical to pBR322. This enabled us to target MC1TK to
the retrieval plasmid backbone by simple recombineering.
MC1TK-Cm plasmid DNA was digested with NotI and
SalI. The 4.2-kb fragment was puriﬁed as described above
for recombineering.
The targeting vectors were transformed into DH10B-l
cells that were selected in Kan/Amp-LB media in 96-well
plates. Overnight cultures were diluted into fresh LB and
incubated for a further 2h. These cells were then heat
shocked at 428C for 15min to induce recombination
activities and were processed for chemical transformation.
We used 100ng puriﬁed MC1TK-Cm cassette for each
recombineering reaction. The recombinant cells were
selected out in Kan/Cm-LB.
Cre orFlpe recombinase expression
To conﬁrm the functionality of loxP, FRT and F3 sites in
the targeting vectors, the targeting vector plasmid DNA
was transformed into EL350 and EL250 E. coli cells that
express Cre and Flpase respectively upon L-arabinose
induction. The procedure was performed as described
previously (10,14).
GenotypingES cells by long-range PCR
AB2.2 ES cells transfected with the linearized targeting
vectors were selected in 150mg/ml G418 (active compo-
nent) and 2mM ganciclovir (Ganc). Genotyping targeted
ES cell clones by long-range PCR was performed as
following. ES cell colonies were picked into 96-well feeder
plates. After 3 days, cells were trypsinized in 50ml trypsin
for 10–15min with subsequent addition of 50ml ES cell
media. Here, 30ml was disposed into two 96-well cell
culture plates that were gelatinized for DNA preparation.
For the remaining cells ( 30ml), 30ml2   freezing media
(DMEM, 20% FCS, 20% DMSO) was added and mixed.
Cells in the plate were kept in a sealed styrofoam box at
 808C. Cells in the DNA plates were allowed to grow for
further 2 days and DNA were prepared as previously
published (26). DNA was dissolved in 30ml water. Here,
2ml of DNA was diluted in 18ml water in a 96-well PCR
plate and heated at 998C for 10min using a PCR machine
to denature DNA. The plate was centrifuged at
3700r.p.m. for 5min. Here, 1ml of the denatured DNA
was used for the long-range PCR. The remaining DNA in
the original DNA plate was used for restriction digestion
and Southern blotting.
PCR ampliﬁcation was carried out using Extensor
Hi-Fidelity PCR Master Mix 2 (2 , ABgene). Here,
12.5ml of the master mix was added to 1ml of template,
1ml of each primer (10mM) and 9.5ml of PCR-grade
water. PCR was performed using PTC-225 PCR machine
(Peltier Thermal Cycler) with the following settings: 948C
for 4min, this was followed by 35 cycles of 948C for 30s,
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(2–3kb). This was then followed by 688C for 10min.
Primers for genotyping Meox1 targeted ES cell clones:











The l phage based recombineering is currently the most
commonly used method for engineering DNA in E. coli.
This is achieved, in many cases, by ﬁrst transforming BAC
DNA into special E. coli strains that harbour a defective
l prophage (14,16). For obscure reasons, some BACs are
more diﬃcult to transform, or the initial transformation
leads to unwanted DNA rearrangements. Furthermore,
re-transformation of BAC DNA from the original library
isolates is not suitable for high-throughput operations. To
address these problems with the current l prophage
recombineering systems, we made new mobile recombi-
neering reagents and used them in a high-throughput
recombineering protocol for making mouse KO targeting
vectors.
Constructionof areplication-defective lphage andpSim
plasmids
To create a mobile system that is suitable to eﬃciently
deliver recombineering function to a large number of
indexed BAC clones or to convert entire libraries, we
constructed a replication-defective l phage l cI857 ind1
CroTYR26amber PGLN59amber rex54 tetRA, which has two
amber mutations in genes Cro and P at codons 26 and 59,
respectively, and a tetracycline-resistance cassette in rex
(Figure 1A).
High-titre lysates of this multiply mutant phage can be
made on strain LE392 carrying tRNA suppressor alleles
for the amber mutants. The resultant mutant l phage
lysate was infectious but did not lyse non-suppressive
strains such as DH10B where most BAC libraries are
constructed and maintained. The lysogens can be easily
selected with tetracycline at 328C.
Besides the new l phage, we have developed and tested
an alternative plasmid-based recombineering system,
pSim, which is a temperature-sensitive, low-copy plasmid
(pSC101) that carries the exo, bet and gam genes under the
control of their native pL operon in a mini-prophage (20)
(Figure 1B). Three versions of this pSim plasmid, pSim-6
(Amp), pSim-17 (Blasticidin) and pSim-18 (Hygromycin),
were constructed and were used for high-throughput
studies. The only diﬀerence among these three plasmids
is that they carry diﬀerent antibiotic-resistant gene-coding
sequences driven by the pRM promoter that also directs the
CI repressor gene transcription. pSim plasmids are easier
to use than the mini-lambda we made previously (27) since
integration of mini-lambda into the E. coli genome is
relatively ineﬃcient. BAC cells harbouring pSim plasmids
showed eﬃcient recombineering in each type of experi-
ment described in this study (data not shown). Details of
using pSim plasmids in recombineering can be found in
the Materials and methods section. Since it is easier to
introduce recombineering functions into 96 BACs in a
96-well plate, or into an entire BAC library, by simple
l phage infection rather than plasmid transformation, we
describe here the new high-throughput recombineering
procedures, focussing on using the replication-defective
l phage.
Recombineering withshort homologyusing chemical trans-
formation in96-well plates
To test recombineering using the replication-defective l,
we infected BAC-C3 (containing mouse Bcl11a gene) with
the phage and used the resultant Tet
R lysogen in the
experiments. The goal was to insert a Neo/Kan cassette
into this BAC by using a 2.8-kb DNA fragment (from
plasmid PL440) in which the Neo/Kan cassette is ﬂanked
by two 400-bp genomic DNA homology arms. The heat-
induced lysogenic cells were electroporated with the DNA
fragment using a conventional E. coli transformation
condition (16). We obtained thousands of Kanamycin-
resistant (Kan
R) recombinant colonies, demonstrating
that the new l was eﬃcient in recombineering. We also
noticed more cells lysed during electroporation compared
to using either regular BAC cells or heat-induced
Figure 1. The new mobile recombineering reagents. (A) A schematic
diagram of the replication-defective l phage with the two amber
mutations in Cro and P genes. Arrows point to the nucleotide changes
in the amber mutations. (B) pSim plasmids provide an alternative
convenient route for recombineering. The Amp coding sequence in
pSim6 plasmid is engineered to either Blasticidin- (pSim17) or
Hygromycin (pSim18)-resistant gene-coding sequences, which are
driven by PRM promoter. All the pSim plasmids have the pSC101
temperature sensitive, low-copy replication origin.
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l prophage (EL350), suggesting that upon heat induction
the slight leakiness of lysis genes S and R might contribute
to the sensitivities of these cells to high voltages (28).
Plating post-electroporation cells on LB plates demon-
strated that 30% of the DH10B-l lysogens survived
electroporation compared to about half of the cells that
survive when regular DH10B cells are used. Importantly,
no noticeable DNA rearrangements were detected in the
BACs after heat induction (data not shown).
To ﬁnd out whether chemical transformation
was suﬃcient for recombineering in the heat-induced
l lysogens, we compared the recombineering eﬃciencies
in BAC-C3 BAC lysogen cells using either chemical
transformation (see Materials and methods section)
or conventional electroporation. With 50ng of the
gel-puriﬁed 2.8-kb fragment from PL440, similar numbers
of Kanamycin-resistant (Kan
R) colonies were obtained
from either chemical transformation (2004Kan
R/3 10
9
surviving cells) or electroporation (3400Kan
R/6 10
8
surviving cells), although the absolute recombineering
eﬃciency of recombinants (Kan
R) versus total survival
cells was eight times lower in chemical transformation.
Nevertheless, chemical transformation is simpler, does not
require any special equipment, and can easily be adapted
into a 96-well format.
In general, 50-bp homology is routinely used for
targeting a selection cassette to the E. coli genome
by recombineering. This is usually achieved by using two
70-mer PCR primers that have 50nt for homology and
20nt for PCR ampliﬁcation. To examine whether the new
l prophage system is suﬃcient to recombine with short
homologies, we replaced the Neo coding sequence in
PL451 (PGK-EM7-Neo-bpA) plasmid (10) with the coding
sequence of a Puromycin resistance gene (Puro), indicating
that the new l phage recombineering system had provided
high enough recombineering eﬃciencies with relatively
short homology arms.
Next, we investigated whether it is possible to obtain
enough recombinants using cells cultured in a small
volume. We repeated the above experiment of replacing
the Neo coding sequence with Puro. We inoculated 50ml
overnight culture into 1ml LB in a 96-well plate for
the 2-h incubation. After chemical transformation, we
obtained  200 Puro
R colonies, demonstrating that it was
indeed feasible to scale down the culture volume to
perform recombineering in a 96-well plate.
Construction of aconditional targeting vector forthe Meox1
gene in96-well plates
We next made a cko targeting vector using the
new recombineering reagents and the 96-well recom-
bineering protocol. The vector design was a cko strategy,
where a reporter is integrated into the targeted allele
to allow the detection of endogenous gene expression (9),
and combined with our past experience in gene targeting
(Figure 2).
To construct a targeting vector, we ﬁrst incorporated a
526-bp Blasticidin selection marker (Bsd) ﬂanked by two
rare cutter sites (I-SceI/I-CeuI) to the 50 of the region to be
deleted (Figure 2A). Empirically, we ﬁnd that smaller
selection cassettes generally give rise to better recom-
bineering eﬃciencies. After the Bsd is integrated to the
BAC, the loxP-F3-Neo-F3 cassette is subsequently tar-
geted to the 30 side of the region to be deleted (Figure 2A).
F3 is a mutant variant of the wild-type FRT site. It can
recombine with another F3 site to excise Neo but not with
wild-type FRT sites (29). The Neo cassette has a PGK
promoter and an EM7 promoter so it is functional in both
mammalian cells and E. coli. Next, the modiﬁed genomic
DNA fragment with the two selection markers (Bsd and
Neo) was retrieved from the BAC to a modiﬁed pBR322
plasmid (PL611) (Figure 2B). We used pBR322 rather
than a pUC19 backbone to reduce the instability problems
associated with cloning mouse genomic DNA into the
very high-copy pUC-type plasmid. Finally, the Bsd
cassette was removed in vitro with I-SceI/I-CeuI double
digestion and replaced with a reporter (lacZ) as illustrated
in Figure 2C. The lacZ reporter, with its splicing acceptor
site (SA) and polyadenylation site, serves to detect
transcription expression of the targeted gene and at the
same time may disrupt the gene and possibly create a loss
of function allele. To produce a cko allele, the lacZ and
Neo cassettes can be excised by expressing Flp either in ES
cells, or preferably in the mouse germline (Figure 3A).
After Cre-loxP-mediated deletion of the genomic region,
FRT and F3 sites remain at the targeted locus, providing
an anchor point for FRT-F3-mediated cassette exchange
in cultured cells (29).
Based on this design and using the 96-well recombineer-
ing reagents and protocol, we made a cko vector of the
mouse Meox1 gene. The KO strategy for the Meox1 locus
is to ﬂank the last two exons with loxP sites to create a
deletion of  3.5kb (Figure 3A). The six primers for
introducing the two selection markers and for retrieving
the genomic DNA fragment were designed by a software
for genome-wide targeting strategies (D.M. and P.L.,
unpublished data). These primers have 70–80nt of mouse
genomic sequences for recombineering homology and
20nt complementary to the selection cassettes
(Supplementary Table 2).
Cells of BAC bMQ-434G24 (containing Meox1),
ordered from an end-sequenced and indexed 129S5 BAC
library (25), were infected by the replication-defective
phage and l lysogenic cells were selected either on Tet-LB
plates or in liquid Tet-LB in a 96-well plate. In the latter
case, because of the high titre of the l lysate, thousands of
cells became l lysogens and the Tet
R lysogenic liquid
culture in the 96-well plate was used for recombineering
the next day. After Meox1 BAC lysogens were heat
induced to express red genes and chemically transformed
with the PCR-ampliﬁed Bsd cassette, recombineering
mixture was selected with 1ml of Bsd-LB media at 328C
in a 96-well plate.
To introduce the 30loxP site, the Bsd
R/Tet
R cells in
a 96-well plate were heat induced and transformed
with PCR-ampliﬁed loxP-F3-PGK-EM7-Neo-F3 cassette.
The transformed cells were selected directly in LB-Kan
media in a 96-well plate.
To retrieve the genomic DNA fragment, PCR-ampliﬁed
retrieval vector (PL611) with 70-bp homology on each side




Up to 100 colonies were usually obtained for each retrieval
experiment in chemical transformation. Analysis of these
colonies showed that many of them were simple rearrange-
ment or end-joining of the original retrieval vector and did
not contain the retrieved fragment, an observation also
made by other laboratories using recombineering to
retrieve or to perform gap repair (Figure 3B, lane 1).
To eliminate this problematic background, we selected
the retrieval transformants directly in Amp-LB media in a
96-well plate and made a mini-preparation from Amp
R
cells that represented a mixture of true recombinants as
well as the background (Figure 3B, lane 2). Because the
correctly recombined plasmid should retain the Bsd and
Neo selection markers targeted to the genomic DNA
region, the background plasmids could easily be elimi-
nated by transforming the plasmid DNA mixture into
regular DH10B or its recombineering-ready sub-strains
(DH10B-l, EL350 or DY380) and selecting transformants
in Kan-LB (Figure 3B, lane 3).
Once the Bsd cassette was replaced by the lacZ reporter,
and the functionality of loxP, and the FRT/F3 sites was
Figure 2. Construction of conditional knockout targeting vectors using the new recombineering reagents. (A) The genomic structure of a locus with
exons 3–5 to be deleted in the cko allele. The Bsd cassette ﬂanked by two rare cutter sites, I-SceI and I-CeuI, is targeted to the 50 side of the intended
deletion region. Subsequently, the loxP-F3-PGK-EM7-Neo-F3 (Neo) cassette is targeted to the 30 side of the deletion region. The point mutation
present in the Neo coding sequence of PL452 and PL451 plasmids (10,36) was corrected in this Neo cassette which resulted in higher resistance to
Kanamycin in E. coli and a 2-fold increase in the number of G418-resistant ES colonies. Coloured lines represent the short homology arms in
recombineering. (B) The genomic DNA fragment is retrieved from the BAC to PL611, which has the Amp
R gene. In a typical cko vector, we choose
4–5-kb genomic DNA as the left homology arm (50), and 2–3kb as the right homology arm (30). The genomic DNA region to be deleted is generally
between 1 and 7kb. (C) The Bsd cassette can conveniently be replaced by a reporter, i.e. lacZ, in a simple ligation reaction. The ﬁnal targeting vector
has the reporter ﬂanked by two FRT sites followed by a loxP site at the 50 side of the intended deletion region, and a F3 ﬂanked Neo cassette
providing positive selection in ES cells. The negative selection marker TK is added to the vector backbone by recombineering. The vector is linearized
with the rare-cutter I-PpoI.
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linearized with I-PpoI prior to being transfected into
AB2.2 mouse ES cells.
Correct recombinant ES clones were identiﬁed by
PCR using external and internal (lacZ or Neo) primers
(Figure 3D), and were conﬁrmed on Southern blots using
external probes (data not shown). Twenty-ﬁve percent of
the G418
rGanc
r clones were correctly targeted at both the
50 and the 30 side, and had the desired lacZ reporter cko of
the Meox1 locus.
Figure 3. Targeting at the mouse Meox1 locus. (A) Construction of the Meox1 conditional knockout (cko) allele using the design depicted in
Figure 2. The lacZ reporter is targeted to the intron 1 and the Neo cassette is in intron 3. Flp excises both lacZ reporter and the Neo cassette,
leaving behind a cko allele. Cre recombinase deletes the region between the two loxP sites. One FRT, one loxP and one F3 site still
remain after Cre-loxP-mediated deletion. (B) Elimination of retrieving background by re-transformation. After the Bsd and Neo cassettes were
targeted to the BAC, the genomic DNA was retrieved to PL611 (Amp
R). Many of the Amp
R colonies were the rearranged PL611 backbone (lane
1). When the plasmid preparation from pooled Amp
R colonies was examined, there were some true retrieved fragments besides the PL611
rearranged band (lane 2). Once the plasmid mixture was re-transformed into DH10B cells that were selected in Kan-LB, only the correctly
recombined plasmid survived and background plasmids were eliminated (lane 3). The correctly retrieved plasmid had the Bsd cassette
and produced the 13.2-kb and 6.8-kb fragments after EcoRV digestion. Arrow points to the rearranged retrieval vector backbone (PL611).
(C) Test of the functionality of FRT, F3 and loxP sites. The ﬁnal targeting vector was digested BamHI which generated four fragments: 17.5, 5.0,
4.5 and 1.5kb. The digestion pattern changed after Flp or Cre excision of the selection cassettes as anticipated. T: targeting vector.
(D) Long-range PCR identiﬁcation of targeted ES clones. The internal primers were from the lacZ or the Neo cassette, and the external ones
from genomic DNA immediately outside the homology arms. The gel image shows PCR ampliﬁcation of two targeted clones.
For the 50 diagnosis, a 6.6-kb fragment was ampliﬁed (lanes 1 and 2) and for the 30 side, the 4.3-kb junction fragment was detected in the
targeted clones.
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We selected 96 genes on the mouse chromosome 11 to
make KO vectors simultaneously because it is one of the
chromosomes sequenced and annotated at the Sanger
Institute. The primers for the 96 KO vectors were
generated by the vector design software (Supplementary
Table 2), and were ordered through the Sanger’s high-
throughput oligo ordering pipeline. The intended deletion
regions in these genes are generally in the range of 3–5kb.
BACs from the 129S5 BAC library corresponding to these
genes were infected with l phage and selected with
tetracycline directly in a 96-well plate in liquid media.
The procedure for recombineering in 96-well format is
depicted in Figure 4.
Escherichia coli DH10B carrying BACs harbouring
diﬀerent genomic inserts grow at diﬀerent rates. To
ensure that at least some cells for any given BAC in the
96-well plate would achieve optimal growth density for
recombineering and transformation, we inoculated various
amounts of the overnight culture of Tet
R lysogens into
0.85ml fresh LB for the 2h incubation at 328C prior to
heat induction. For example, we usually inoculated 25, 35,
45, 55ml of the overnight cell culture into 850ml fresh LB in
four wells of four 96-well plates respectively (Figure 5).
This added step should increase the likelihood that some
cells in at least one well for any BAC would reach optimal
growth density (log phase) for heat induction and
recombineering after 2h incubation at 328C.
In our ﬁrst attempt to manipulate 96 BACs simulta-
neously, we obtained 94 retrieved targeting vectors that
were subsequently conﬁrmed by sequencing the junctions
between the plasmid backbone and the genomic DNA
inserts, and by restriction digestion. Figure 6 shows the
restriction digestion patterns of these KO vectors.
DISCUSSION
To develop a robust high-throughput recombineering
protocol, we developed two mobile recombineering-
enabling systems. The l phage provides a very eﬃcient
Figure 4. Schematic diagram of recombineering steps in 96-well plates. Ninety-six BACs corresponding to the 96 genes on the mouse chromosome 11
were seeded into a 96-well plate. The BAC cells were infected by the replication-defective l phage and lysogens were selected in Tet-LB media. The
Bsd and Neo cassettes were consecutively targeted to the BACs in recombineering reactions performed in 96-well plates. Retrieved plasmid
preparations were transformed back into DH10B cells to eliminate rearranged retrieval plasmid backbone. MC1TK, with a Chloramphenicol (Cm)
cassette, was targeted to PL611 to provide a negative selection in ES cells.
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many BAC clones or an entire BAC library by simple
phage infection. On the other hand, pSim plasmids serve
as an eﬀective alternative vehicle for the same purpose.
Both of these recombination systems are robust. In this
article, we primarily described the replication-defective
l system, but pSim plasmids delivered similar results and
might be more convenient to use if one needs to
manipulate only one or a few BACs using the standard
recombineering protocols because most molecular biology
laboratories are more familiar with using plasmid
transformation.
We also improved the previous recombineering proto-
cols at several steps. For example, we used a relatively
large amount of PCR products (3mg) in transformation in
order to compensate for using fewer E. coli cells growing
in 96-well plates and for the less eﬃcient chemical
transformation. To obtain clean PCR-ampliﬁed selection
cassettes, we used E. coli Exo nuclease I to digest the
excessive PCR primers and ssDNA so that any potential
competition between the single-strand primers and the
double-strand PCR products for the same target DNA in
recombineering would be eliminated (see Materials and
methods section). When a selection marker is targeted to
single-copy BACs, the genomic region can have signiﬁcant
eﬀects on expression of this marker in E. coli and thus
on detection of recombineering events. Therefore, we used
Figure 5. Increasing the recombineering eﬃciency by inoculating
diﬀerent amounts of cells in 96-well plates. Escherichia coli cells
harbouring BACs are growing diﬀerently due to the nature and the
sizes of genomic DNA inserts. Eﬃcient recombineering and transfor-
mation require cells growing in log phase. To increase the likelihood
that cells of a particular BAC reach the optimal growth condition prior
to heat induction and recombineering, four 96-well plates were used for
the 2h culture. Each plate had diﬀerent amounts of the overnight
culture. Cells from the four plates were combined after heat induction
and were transformed with PCR products.
Figure 6. Targeting vectors constructed in 96-well plates. We started
with 96 BACs in a 96-well plate and, after three rounds of
recombineering, obtained 94 vectors. Recombineering did not work
for the two failed BACs (lanes A8 and H3) at the Bsd targeting step
because these two wells were empty or clear after Bsd selection. The gel
image shows the BamHI restriction digestion patterns of these
plasmids. The vectors still carried the Bsd cassette, which could be
replaced by various reporters.
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PGK-EM7-Neo-bpA (Figure 2).
To increase the chance that for any given BAC at least
some cells would be in the optimal growth phase for
recombineering or transformation, we inoculated diﬀerent
amounts of overnight cultures from one 96-well plate to
four 96-well plates for the 328C–2h incubation prior
to heat induction (see Figure 5). In practice, this did
not substantially increase the workload because the
recombineering procedure itself requires a minimal
amount of physical work. We found that many of the
Amp
R colonies in retrieval experiments were end-joined
products of the linear PCR-ampliﬁed retrieval plasmid
backbone. This background was completely eliminated by
transforming mini-prepared DNA of the retrieved plasmid
mixture to E. coli and selecting cells in Kan-LB, thus
avoiding picking and characterizing individual colonies.
It is known that increased homology length improves
recombineering eﬃciencies (12,16,30,31) and using
PCR-ampliﬁed long homology arms (200–500bp) further
substantially improved recombineering reliability and
eﬃciency (10,31). However, using PCR-ampliﬁed long
homology arms is time consuming and is not suitable for a
96-well-plate-based recombineering protocol. Therefore,
we chose 70–80bp homology in this study even though
50bp might be suﬃcient for a majority of the recom-
bineering reactions. The relatively long homology
(70–80bp) should reduce the impact of SNPs among
mouse strains and short stretches of identical sequences in
the homology arms on recombineering eﬃciencies (32).
Using the new l phage system, we demonstrated that
chemical transformation yielded suﬃcient recombinants.
This has enabled us to easily perform recombineering
in 96-well plates. Not surprisingly, BAC cells containing
the l lysogen or harbouring the pSim plasmids
were very eﬃcient in recombineering using conventional
electroporation protocols (16) (data not shown).
A recent publication has also demonstrated that recombi-
neering using l red genes, together with a transiently
supplied RecA function, worked well in manipulating
Caenorhabditis elegans BACs using E. coli cells cultured in
eppendorf tubes (33). The system we described here takes
advantage of growing cells in 96-well plates, uses chemical
transformation and is based on the very eﬃcient l
recombination system where all three red genes are in
their native operon and are controlled by the strong pL
promoter. Importantly, our system does not require RecA
for eﬃcient recombineering, the function of which can
lead to rearrangements of mammalian DNA in BACs.
During the process of developing the new recombineering
system, we made 103 targeting vectors out of the 105
mouse genes on chromosome 11 that were attempted
(Supplementary Table 1). These vectors include the ﬁrst
vector (Meox1) made completely in 96-well plates, then
the 8 vectors made simultaneously (data not shown) and
ﬁnally 96 vectors constructed at once in a scaled-up
operation.
The basic targeting vector design presented in this study
comes from many years of gene targeting experience of the
authors, even though the KO strategy, the selection
markers and the use of loxP, FRT and F3 sites described
in this article can all vary depending on individual
research purposes. In general, we choose a long
50 homology arm so as to survive cellular nuclease attacks,
and a shorter 30 homology arm to minimize the size of
the vector and to facilitate PCR-mediated genotyping.
In the plasmid vector, the negative selection marker
(MC1TK) is adjacent to the 30 arm and is protected by the
rest of the plasmid backbone. Additionally, the use of
PGK-EM7-Neo-bpA as the positive selection marker for
homologous recombination in ES cells makes it possible
to target genes that are both expressed and non-expressed
in ES cells. For targeting in ES cells, the vectors are
linearized at the 50 side to ensure that the basal
transcription of a locus and the initiation of homologous
recombination are coordinated (34,35), although we have
not tested whether this coordination have an eﬀect on the
targeting eﬃciency. Nevertheless, the targeting vectors
conﬁgured in this way, for inserting a selection cassette,
have generally given rise to correct targeting frequencies
that are in the range of 30–95% of the stable mouse ES
cell transfectants, regardless of the expression status of a
locus in ES cells. The genomic DNA regions between the
two loxP sites in our conditional targeting vectors can be
as large as 7.0kb without reducing the targeting frequen-
cies in ES cells. Our vectors therefore can be used to delete
multiple exons after Cre-loxP recombination and generate
null alleles. Using the recombineering system described in
this study, we have recently generated the lacZ-tagged cko
mouse lines for Bcl11a and Bcl11b, and obtained the true
cko alleles after Flpe excised lacZ and Neo in the germline
(S.C.L. and P.L., unpublished data). X-gal staining of the
heterozygotes with the lacZ has demonstrated distinct
expression patterns of the genes in embryonic develop-
ment (Supplementary Figure 1).
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